Increased Osteoprotegerin Levels in Cushing’s Syndrome Are Associated with an Adverse Cardiovascular Risk Profile | Zendy

Andrea Dovio | Zendy; Barbara Allasino | Zendy; Enrico Palmas | Zendy; M. Ventura | Zendy; Anna Pia | Zendy; L. Saba | Zendy; Emiliano Aroasio | Zendy; Massimo Terzolo | Zendy; Alberto Angeli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increased Osteoprotegerin Levels in Cushing’s Syndrome Are Associated with an Adverse Cardiovascular Risk Profile

Author(s) -

Andrea Dovio,

Barbara Allasino,

Enrico Palmas,

M. Ventura,

Anna Pia,

L. Saba,

Emiliano Aroasio,

Massimo Terzolo,

Alberto Angeli

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2283

Subject(s) - osteoprotegerin , medicine , context (archaeology) , endocrinology , adverse effect , disease , cardiology , receptor , biology , paleontology , activator (genetics)

Patients with Cushing's syndrome (CS) have a mortality rate four times higher than age- and sex-matched subjects, mainly due to cardiovascular events. Serum osteoprotegerin (OPG) levels are increased in patients with cardiovascular disease and/or excess bone resorption.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research